Expert Discusses Impact of Genetic Testing in Breast Cancer
November 29th 2017Laura J. van’t Veer, PhD, discusses determining more accurate methods of treatment for patients with early- and late-stage breast cancer based on advances in genetic testing, specifically the 70-gene prognostic signature.